Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd. (China) holds 21 active US FDA Type II Drug Master Files and has DMF or CEP filings on record for 20 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sichuan Kelun Pharmaceutical Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sichuan-kelun-pharmaceutical-co-ltd

Overview

Sichuan Kelun Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in China, focused on research, development, and manufacturing of a wide range of pharmaceutical products. The company is known for its emphasis on innovation in the development of novel therapeutics, particularly in the fields of oncology and anti-infectives.

Core services & business areas

Drug DevelopmentAPI ProductionFormulationRegulatory Affairs Support

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Sichuan Kelun Pharmaceutical Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Sichuan Kelun Pharmaceutical Co., Ltd. holds 21 active (21 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ATOSIBAN ACETATEActive2026-09-22
  • REGORAFENIB MONOHYDRATEActive2026-09-21
  • COCARBOXYLASE TETRAHYDRATEActive2026-09-05
  • NIRAPARIB TOSYLATEActive2026-06-30
  • NETUPITANTActive2025-12-29
  • APREPITANTActive2025-12-15
  • NERATINIB MALEATEActive2025-12-15
  • REGORAFENIBActive2025-10-27
  • IBRUTINIBActive2025-09-28
  • FINERENONEActive2025-07-31
  • PEMAFIBRATEActive2025-06-17
  • APALUTAMIDEActive2025-05-29
  • SIPONIMODActive2025-05-22
  • POSACONAZOLEActive2025-04-17
  • OMADACYCLINE TOSYLATEActive2025-03-26
  • SACUBITRIL VALSARTAN SODIUMActive2025-02-27
  • ENZALUTAMIDEActive2024-12-19
  • OLAPARIBActive2024-10-16
  • EMPAGLIFLOZINActive2024-09-06
  • SILDENAFIL CITRATEActive2023-06-02
  • NINTEDANIB ESYLATEActive2023-03-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Sichuan Kelun Pharmaceutical Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Sichuan Kelun Pharmaceutical Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.